Q4 2024 Management View CEO Bill Stone reported record financial results for Q4 2024, including adjusted revenue of $1.531 billion, up 8.4%, and adjusted diluted EPS of $1.58, marking a 25.4% increase ...
Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback